The effect of preexisting medical comorbidities on the preeclamptic phenotype: a retrospective cohort study

References

• AbouZahr C. Global burden of maternal death and disability. Br Med Bull. 2003;67(1):1–11.
   PubMed Web of Science ®Google Scholar
• Yanit KE, Snowden JM, Cheng YW, et al. The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes. Am J Obstet Gynecol. 2012;207(4):333.e1-.e6.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127 e1–6.
   PubMed Web of Science ®Google Scholar
• Kendrick J, Sharma S, Holmen J, et al. Kidney disease and maternal and fetal outcomes in pregnancy. Am J Kidney Dis. 2015;66(1):55–59.
   PubMed Web of Science ®Google Scholar
• Saccone G, Berghella V, Maruotti GM, et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017;216(5):525e1–e12 .
   Web of Science ®Google Scholar
• Bartsch E, Medcalf KE, Park AL, et al. High risk of pre-eclampsia identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753.
   PubMed Web of Science ®Google Scholar
• Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010;12(6):448–455.
   PubMed Web of Science ®Google Scholar
• Mak A, Ny K, Schwarz H, et al. Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression. Sci Rep. 2017;7(1):7320.
   PubMedGoogle Scholar
• Velásquez M, Rojas M, Abrahams VM, et al. Mechanisms of endothelial dysfunction in antiphospholipid syndrome: association with clinical manifestations. Front Physiol. 2018;9(1840). DOI:https://doi.org/10.3389/fphys.2018.01840
   Google Scholar
• Avogaro A, Albiero M, Menegazzo L, et al. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care. 2011;34(Suppl 2):S285–S90.
   PubMedGoogle Scholar
• Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clin Chim Acta. 2010;411(19–20):1412–1420.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
   PubMed Web of Science ®Google Scholar
• National Institute of Health Care and Excellence. Hypertension in pregnancy: diagnosis and management (NG133). NICE guideline. 2019.
   Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206(1):58.e1-.e8.
   PubMed Web of Science ®Google Scholar
• Doherty A, Carvalho JCA, Drewlo S, et al. Altered hemodynamics and hyperuricemia accompany an elevated sFlt-1/PlGF ratio before the onset of early severe Preeclampsia. J Obstet Gynaecology Canada. 2014;36(8):692–700.
   PubMedGoogle Scholar
• Pinheiro CC, Rayol P, Gozzani L, et al. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia. Prenat Diagn. 2014;34(11):1084–1092.
   PubMed Web of Science ®Google Scholar
• Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected Preeclampsia. Circulation. 2012;125(7):911–919.
   PubMed Web of Science ®Google Scholar
• Rana S, Schnettler WT, Powe C, et al. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens. 2013;32(2):189–201.
   Web of Science ®Google Scholar
• Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS ONE. 2010;5(10):e13263.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Duzyj CM, Yadava S, et al. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension. 2019;74(5):1089–1095.
   PubMed Web of Science ®Google Scholar
• Ward MC, Agarwal A, Bish M, et al. Trends in obesity and impact on obstetric outcomes in a regional hospital in Victoria, Australia. Aust NZ J Obstetrics Gynaecol. 2020;60(2):204–211.
   PubMed Web of Science ®Google Scholar
• Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open. 2016;6(1):e009494.
   PubMed Web of Science ®Google Scholar
• Tranquili AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensivedisorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97–104.
   PubMed Web of Science ®Google Scholar
• Brown M, Magee L, and Kenny L, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:28-29 .
   Web of Science ®Google Scholar
• Townsend R, O’Brien P, Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control. 2016;9:79–94.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynaecologists. ACOG practice bulletin No. 203: chronic hypertension in pregnancy. Obstetrics Gynecol. 2019;133(1):e29.
   Web of Science ®Google Scholar
• Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–s22.
   PubMed Web of Science ®Google Scholar
• Bell MJ. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs. 2010;39(5):510–518.
   PubMed Web of Science ®Google Scholar
• Ananth C, Vintzileos A. Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol. 2008;35(1):53–67. viii.
   PubMed Web of Science ®Google Scholar
• Lowe SA, Bowyer L, Lust K, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55(5):1–29.
   PubMed Web of Science ®Google Scholar
• Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979–988.
   PubMed Web of Science ®Google Scholar
• Reddy U, Ko C-W WM. Early term births (37-38 weeks) are associated with increased mortality. Am J Clin Exp Obstet Gynecol. 2006;195(6):S202.
   Google Scholar
• Parikh LI, Reddy UM, Männistö T, et al. Neonatal outcomes in early term birth. Am J Obstet Gynecol. 2014;211(3):265.e1-.e11.
   PubMed Web of Science ®Google Scholar
• Tita ATN, Jablonski KA, Bailit JL, et al. Neonatal outcomes of elective early-term births after demonstrated fetal lung maturity. Am J Clin Exp Obstet Gynecol. 2018;219(3):296.e1-.e8.
   Google Scholar
• Murray S, Shenkin S, McIntosh K, et al. Long term cognitive outcomes of early term (37-38 weeks) and late preterm (34-36 weeks) births: a systematic review [version 1; peer review: 1 approved, 2 approved with reservations]. Wellcome Open Res. 2017;2(101):101.
   PubMedGoogle Scholar
• Tuuli MG, Rampersad R, Stamilio D, et al. Perinatal outcomes in women with preeclampsia and superimposed preeclampsia: do they differ? Am J Obstet Gynecol. 2011;204(6):508.e1-.e7.
   PubMed Web of Science ®Google Scholar